AI-generated summary
The authors report a prospective study of 16 adults with atrophic acne scars and Fitzpatrick skin types III-IV treated with a 675-nm nonablative laser over three monthly sessions. They describe improved Goodman and Baron scores and Antera 3D measures of texture and volume at six months, with transient, low-incidence adverse events. The study was small and uncontrolled, so the findings are preliminary.
- Participants
- 16
- Who or what was studied
- Adults with atrophic acne scars and Fitzpatrick skin types III-IV (Asian patients)
- Wavelengths
- 675 nm
- Limits stated in the abstract
- The abstract describes a small prospective study of 16 patients without a control group, so the results are preliminary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Trial registration, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.